Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check3 days agoChange DetectedA new revision entry (v3.3.4) was added, and the previous revision (v3.3.3) was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision history now includes Revision: v3.3.3, and entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedA new record revision v3.3.2 was added to the history, and the prior revision v3.2.0 was removed from the list.SummaryDifference0.1%

- Check59 days agoChange DetectedA government funding operating-status notice was removed from the page.SummaryDifference0.7%

- Check74 days agoChange DetectedNew version entries appear in the Record History, adding more submitted changes and showing updates to study status and locations.SummaryDifference0.1%

- Check103 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference12%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.